Senior insider sale
Interim CFO at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$238.3K
15.96K shares
What this filing means
SULLIVAN CHRISTOPHER RYAN plans to sell 15.96K shares of AVALO THERAPEUTICS, INC. valued at approximately $238.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/1/2026ACC: 0001950047-26-003175
Officer· Interim CFO
Since Apr 2020
15.96K
Shares to sell
$238.3K
Approx. market value
15.96K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/28/2026
15.96KTotal acquired15.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/28/2026 | Restricted Stock Units N/A | 15.96K | — |
| Total | 15.96K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
15.96K
Market value
$238.3K
4/1/2026
Total
Units
15.96K
Value
$238.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/1/2026 | 15.96K | $238.3K | NASDAQ | Planned |
| Total | 15.96K | $238.3K | ||